Trials / Withdrawn
WithdrawnNCT05589857
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 5 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
Tto learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients following surgery.
Detailed description
Primary Objective: To assess the efficacy of SpellBound's AR-enabled scavenger hunt to reduce the rate of additional inpatient opioid use in pediatric cancer patients who are chronic/tolerant opioid users undergoing surgery compared to a control non-AR game in a randomized controlled trial. Secondary Objectives: To assess the impact of AR versus non-AR control technology in pediatric oncology patients, including: * Inpatient opioid use * Average daily inpatient pain score * Number of opioid requests during hospital stay * Inpatient PedsQL (quality of life) questionnaire score * Ambulation/"out of bed" movement * Number days to discharge-ready status * Patient experience assessed by satisfaction scores on questionnaire designed by MD Anderson Cancer Center Child Life team * Outpatient opioid use reported at 30, 60, 90 days. * Outpatient pain scores reported at 30, 60, 90 days * Outpatient PedsQL scores reported at 30, 60, and 90 days * Potential adverse events related to the use of AR (i.e., falls).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IPAD | Participants will play a game using the iPad's standard camera, which will show you your hospital room and the decal/stickers s as they appear in the real world. |
| DEVICE | Augmented Reality | Participants will play a game through (device camera and application) that add virtual or digital characters and items that let participants view the real world. |
Timeline
- Start date
- 2022-10-25
- Primary completion
- 2024-05-09
- Completion
- 2024-05-09
- First posted
- 2022-10-21
- Last updated
- 2024-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05589857. Inclusion in this directory is not an endorsement.